Business ❯ Corporate Strategy ❯ Mergers and Acquisitions ❯ Market Trends

Investor Relations

AbbVie Agrees to Buy Apogee Therapeutics for $10.9 Billion

The acquisition secures an IL‑13 antibody with potential long‑interval dosing that positions AbbVie to replenish its immunology pipeline

Lilly to Acquire Centessa for $6.3 Billion to Add Orexin Sleep Drugs

IBM to Acquire Confluent for $11 Billion in All-Cash Deal